Evidence map›Paper›PMID 38675593›Full record

ArticleMolecules (Basel, Switzerland)2024

Synthesis of Sucrose-Mimicking Disaccharide by Intramolecular Aglycone Delivery.

Kanae Sano, Akihiro Ishiwata, Hiroto Takamori, Takashi Kikuma, Katsunori Tanaka, Yukishige Ito, Yoichi Takeda

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Carbohydrate Chemistry II.Molecules (Basel, Switzerland) · 2025
    Article
  2. Approaches to stereoselective 1,1'-glycosylation.Beilstein journal of organic chemistry · 2025
    Review
  3. ZnIMolecules (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kanae SanoDepartment of Biotechnology, College of Life Sciences, Ritsumeikan University, Kusatsu 525-8577, Japan.
Akihiro IshiwataRIKEN Cluster for Pioneering Research, Wako 351-0198, Japan.ORCID 0000-0002-5542-2214
Hiroto TakamoriDepartment of Biotechnology, College of Life Sciences, Ritsumeikan University, Kusatsu 525-8577, Japan.
Takashi KikumaDepartment of Biotechnology, College of Life Sciences, Ritsumeikan University, Kusatsu 525-8577, Japan.
Katsunori TanakaRIKEN Cluster for Pioneering Research, Wako 351-0198, Japan.
Yukishige ItoRIKEN Cluster for Pioneering Research, Wako 351-0198, Japan.ORCID 0000-0001-6251-7249
Yoichi TakedaDepartment of Biotechnology, College of Life Sciences, Ritsumeikan University, Kusatsu 525-8577, Japan.ORCID 0000-0002-7146-3585
Ritsumeikan University · JPPioneer (Japan) · JPTokyo Institute of Technology · JP

Funding

Japan Society for the Promotion of Science JP16H06290Japan Society for the Promotion of Science JP21K05282Japan Society for the Promotion of Science JP22H02196Mizutani Foundation for Glycoscience research grants in 2023
6 · The paper itself

Abstract

Rare sugars are known for their ability to suppress postprandial blood glucose levels. Therefore, oligosaccharides and disaccharides derived from rare sugars could potentially serve as functional sweeteners. A disaccharide [α-d-allopyranosyl-(1→2)-β-d-psicofuranoside] mimicking sucrose was synthesized from rare monosaccharides D-allose and D-psicose. Glycosylation using the intermolecular aglycon delivery (IAD) method was employed to selectively form 1,2-

Indexed as

DisaccharidesFructoseGlucoseSucroseGlycosylationSweetening AgentsalloseDisaccharidesFructoseGlucosepsicoseSucroseSweetening Agentsalloseglycosylationintramolecular aglycone deliverypsicoserare sugar

Identifiers

PMID38675593
PMCPMC11051705
OpenAlexW4394809448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.